quinazolines has been researched along with hexamethylene bisacetamide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grainger, DJ; Hesketh, TR; Metcalfe, JC; Weissberg, PL | 1 |
| Arteaga, CL; Brown, TD; Craig, JB; Harman, GS; Koeller, JM; Kuhn, JG; Von Hoff, DD; Weiss, GR | 1 |
| Barat, C; Dental, C; Ouellet, M; Proust, A; Tremblay, MJ | 1 |
1 review(s) available for quinazolines and hexamethylene bisacetamide
| Article | Year |
|---|---|
New anticancer agents.
Topics: Acetamides; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Flavonoids; Gallium; Humans; Mitolactol; Mitoxantrone; Organoplatinum Compounds; Pentostatin; Quinazolines; Ribavirin; Trimetrexate; Vidarabine Phosphate | 1987 |
2 other study(ies) available for quinazolines and hexamethylene bisacetamide
| Article | Year |
|---|---|
Hexamethylenebisacetamide selectively inhibits the proliferation of human and rat vascular smooth-muscle cells.
Topics: Acetamides; Animals; Cell Division; Cells, Cultured; Coumarins; DNA Replication; Endothelium, Vascular; Fibroblasts; Hematinics; Humans; Kinetics; Muscle, Smooth, Vascular; Quinazolines; Quinazolinones; Rats; Thymidine | 1992 |
HIV-1 Latency-Reversing Agents Prostratin and Bryostatin-1 Induce Blood-Brain Barrier Disruption/Inflammation and Modulate Leukocyte Adhesion/Transmigration.
Topics: Acetamides; Azacitidine; Azepines; Blood-Brain Barrier; Bryostatins; Cell Adhesion; Cell Adhesion Molecules; Cell Movement; Cells, Cultured; Chemokine CCL2; Cytokines; Decitabine; HIV-1; Humans; Inflammation; Intercellular Adhesion Molecule-1; Leukocytes; Phorbol Esters; Quinazolines; Receptors, Cell Surface; Virus Latency | 2017 |